Yahoo Web Search

Search results

1. • Age-Related Macular Degeneration: Putting a Hole in Our World

     WebMD· 1 day ago

     When we’re young, we take our macula for granted. At the center of our retina – the deepest layer of the eye that’s chock-full of photoreceptors and that confers color to our world – the macula ...

2. • Lineage Cell Therapeutics Q1 2024 Earnings: Aligns with EPS Projections Amidst Revenue Declines

     GuruFocus.com via Yahoo Finance· 1 day ago

     The clinical-stage biotechnology company, known for its innovative cell therapies targeting degenerative diseases, reported earnings and operational updates that reflect..

3. • STEALTH BIOTHERAPEUTICS' BARTH SYNDROME NDA RECEIVES PRIORITY REVIEW DESIGNATION

     FOX 59 Indianapolis· 4 days ago

     Stealth BioTherapeutics, a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial ...

4. • Stealth BioTherapeutics to Present at JMP Citizens Life Sciences Conference

     FOX 4 Kansas City· 5 days ago

     Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies ...

5. • 

     These 2 ‘Strong Buy’ Penny Stocks Could Surge Over 400%, Says Oppenheimer

     TipRanks via Yahoo Finance· 2 days ago

     Risk and reward are the yin and yang of stock trading, the two essential yet opposing forces in...

6. • Head to Head Survey: Cognition Therapeutics (NASDAQ:CGTX) vs. Opthea (NASDAQ:OPT)

     ETF DAILY NEWS· 7 days ago

     Cognition Therapeutics (NASDAQ:CGTX – Get Free Report) and Opthea (NASDAQ:OPT – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the ...

7. • Skye Bioscience (NASDAQ:SKYE) Shares Down 1.8%

     ETF DAILY NEWS· 3 days ago

     Skye Bioscience, Inc. (NASDAQ:SKYE – Get Free Report)’s stock price was down 1.8% during trading on Wednesday . The company traded as low as $12.32 and last traded at $12.50. Approximately 29,170 ...

8. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

     Roanoke-Chowan News-Herald· 5 days ago

     (NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for wet ...

9. • Small Business - The Brewton Standard | The Brewton Standard

     The Brewton Standard· 5 days ago

     Webinar, moderated by Cantor Fitzgerald, will be held on Monday, May 13, 2024, at 2:00 p.m. ET Discussion will feature Dr. Michel Michaelides, leading expert in the field of inherited eye disease in adults and children SAN DIEGO, May 06

10. • HC Wainwright Reaffirms “Buy” Rating for Lineage Cell Therapeutics (NYSEAMERICAN:LCTX)

      ETF DAILY NEWS· 3 days ago

      HC Wainwright reissued their buy rating on shares of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX – Free Report) in a research report report published on Monday, Benzinga reports. The firm currently ...